Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Submitted by
admin
on November 6, 2009 - 10:45am
Source:
Yahoo/AP
News Tags:
Xyrem
earnings
Jazz Pharmaceuticals
Headline:
Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Do Not Allow Advertisers to Use My Personal information
